These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12418199)

  • 1. Use of laser capture microscopy in the analysis of mouse models of human diseases.
    Arin MJ; Roop DR
    Methods Enzymol; 2002; 356():207-15. PubMed ID: 12418199
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessons from keratin transgenic and knockout mice.
    Magin TM
    Subcell Biochem; 1998; 31():141-72. PubMed ID: 9932492
    [No Abstract]   [Full Text] [Related]  

  • 3. Inducible mouse models for inherited skin diseases: implications for skin gene therapy.
    Arin MJ; Roop DR
    Cells Tissues Organs; 2004; 177(3):160-8. PubMed ID: 15388990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic bases of epidermolysis bullosa simplex and epidermolytic hyperkeratosis.
    Fuchs E; Coulombe P; Cheng J; Chan YM; Hutton E; Syder A; Degenstein L; Yu QC; Letai A; Vassar R
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):25S-30S. PubMed ID: 7525738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Keratin diseases].
    Jensen PK; Sørensen CB; Andresen BS; Brandrup F; Veien NK; Buus SK; Gregersen N; Bolund L
    Ugeskr Laeger; 2000 Mar; 162(13):1867-72. PubMed ID: 10765692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic skin disorders of keratin.
    Fuchs E
    J Invest Dermatol; 1992 Dec; 99(6):671-4. PubMed ID: 1281858
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidermolytic hyperkeratosis and epidermolysis bullosa simplex caused by frameshift mutations altering the v2 tail domains of keratin 1 and keratin 5.
    Sprecher E; Yosipovitch G; Bergman R; Ciubutaro D; Indelman M; Pfendner E; Goh LC; Miller CJ; Uitto J; Richard G
    J Invest Dermatol; 2003 Apr; 120(4):623-6. PubMed ID: 12648226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage of the epidermolytic hyperkeratosis phenotype and the region of the type II keratin gene cluster on chromosome 12.
    Bonifas JM; Bare JW; Chen MA; Lee MK; Slater CA; Goldsmith LA; Epstein EH
    J Invest Dermatol; 1992 Nov; 99(5):524-7. PubMed ID: 1385543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal disease: faulty keratin filaments take their toll.
    Compton JG
    Nat Genet; 1994 Jan; 6(1):6-7. PubMed ID: 7511022
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel mechanism of revertant mosaicism in Dowling-Meara epidermolysis bullosa simplex.
    Smith FJ; Morley SM; McLean WH
    J Invest Dermatol; 2004 Jan; 122(1):73-7. PubMed ID: 14962092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidermic genodermatoses: models of current approch in dermatology].
    Hohl D
    Rev Med Suisse Romande; 1994 Mar; 114(3):277-80. PubMed ID: 8171239
    [No Abstract]   [Full Text] [Related]  

  • 12. Partial revertant mosaicism of keratin 14 in a patient with recessive epidermolysis bullosa simplex.
    Schuilenga-Hut PH; Scheffer H; Pas HH; Nijenhuis M; Buys CH; Jonkman MF
    J Invest Dermatol; 2002 Apr; 118(4):626-30. PubMed ID: 11918708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy.
    Cao T; Longley MA; Wang XJ; Roop DR
    J Cell Biol; 2001 Feb; 152(3):651-6. PubMed ID: 11157990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the genes for epidermal keratins in epidermolysis bullosa and epidermolytic hyperkeratosis.
    Leigh IM; Lane EB
    Arch Dermatol; 1993 Dec; 129(12):1571-7. PubMed ID: 7504434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe palmo-plantar hyperkeratosis in Dowling-Meara epidermolysis bullosa simplex caused by a mutation in the keratin 14 gene (KRT14).
    Shemanko CS; Mellerio JE; Tidman MJ; Lane EB; Eady RA
    J Invest Dermatol; 1998 Nov; 111(5):893-5. PubMed ID: 9804355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild recessive epidermolytic hyperkeratosis associated with a novel keratin 10 donor splice-site mutation in a family of Norfolk terrier dogs.
    Credille KM; Barnhart KF; Minor JS; Dunstan RW
    Br J Dermatol; 2005 Jul; 153(1):51-8. PubMed ID: 16029326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel substitution in keratin 10 in epidermolytic hyperkeratosis.
    Arin MJ; Longley MA; Anton-Lamprecht I; Kurze G; Huber M; Hohl D; Rothnagel JA; Roop DR
    J Invest Dermatol; 1999 Apr; 112(4):506-8. PubMed ID: 10201536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete cytolysis and neonatal lethality in keratin 5 knockout mice reveal its fundamental role in skin integrity and in epidermolysis bullosa simplex.
    Peters B; Kirfel J; Büssow H; Vidal M; Magin TM
    Mol Biol Cell; 2001 Jun; 12(6):1775-89. PubMed ID: 11408584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular genetics of keratin disorders.
    Smith F
    Am J Clin Dermatol; 2003; 4(5):347-64. PubMed ID: 12688839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic approaches to understanding the keratinopathies.
    Bale SJ; DiGiovanna JJ
    Adv Dermatol; 1997; 12():99-113; discussion 114. PubMed ID: 8973737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.